The Centre for Stem Cell Biology (CSCB) is recognized internationally as a Centre of Excellence for research on pluripotent stem cells. The research and discoveries of the CSCB are central to the long-term goal of developing clinical applications for pluripotent stem cells in regenerative medicine.
We were the first laboratory to undertake research on human embryonic stem cells in the UK in 1999 and have played a major role in training scientists in this dynamic field. The Centre complements the overall strength in Developmental Biology and Medicine at the University of Sheffield.
We coordinate the International Stem Cell Initiative, an international consortium of laboratories defining standards. It is also the main partner in ESTOOLS, an EU funded collaboration of researchers developing technologies for embryonic stem cells.
The expertise and excellent facilities of the CSCB represents a significant opportunity for collaborative activity with all organisations involved in pluripotent stem cell research.
| International Symposium sponsored by the UKIERI |
Human Pluripotent Stem Cells: Progress to TherapyContributions from Developmental BiologySheffield, UK 8th to 10th April, 2013Organisers: Peter W. Andrews (UK), Harry Moore (UK), Maneesha Inamdar (India)
Considerable progress has already been made and, today, applications in all of these areas are now on the horizon, and some clinical trials for regenerative medicine have begun. However, much still remains to be done, and our knowledge of the mechanisms that guide development of the embryo is central to understanding how to manipulate pluripotent stem cells. In this meeting we will bring together key researchers from India and the UK to discuss the progress in developing applications for pluripotent human stem cells and to address how developmental biology is contributing to that progress Speakers include:
We will be holding a poster session, abstracts are invited. Please email Nick Childs at N.Childs@sheffield.ac.uk by Friday 8th March 2013. Registration will be open shortly, £25 early bird discounted symposium registration, £40 conference dinner.
|
The past 15 years have seen a rapid growth in interest in human pluripotent stem cells, first embryonic stem cells and, more recently, induced pluripotent stem cells, not only for regenerative medicine but also for toxicology, disease modelling and drug discovery. Development of these applications depends on our fundamental understanding of how such cells make fate decisions between self-renewal on the one hand, and differentiation into distinct lineages on the other. Latest News
Discovery Night at the University of Sheffield
The Stem Cell promise: Exploring the most potent stem cells for future clinical treatments
Monday 18 March 2013
Time: 4 - 8.30pm
Place: BMS conference room. Read more.
Closer to a cure for deafness
Human embryonic stem cells could help to treat deafness. Research from the CSCB Rivolta lab means a cure for deafness is a step closer. Read more.
Deaf gerbils 'hear again' after stem cell cure
BBC video report on Centre member, Dr. Marcelo Rivolta's latest research. Read more.
EU Law, Patents and embryonic stem Cells
The Centre for Stem Cell Biology is dismayed by the recent ruling by the European Court that patents involving human embryonic stem cells would be against public morality (C-34/10, Prof. Dr. Oliver Brüstle v Greenpeace e.V.) and therefore cannot be granted in the EU. Read more.
